Sclerotherapy for the recurrent granulomatous epulis with pingyangmycin.
BACKGROUND
Relapse of granulomatous epulis is common after surgery because of local irritations, hormonal level in vivo, or incomplete resection. Currently, if recurrence occurs, then extraction of the teeth adjacent to the lesion is commonly performed, which may influence the aesthetics or masticatory function. Thus, a more effective and less aggressive treatment method is urgently demanded, particularly for the recurring lesion. This study investigated the effects of the intralesional pingyangmycin (PYM) injections for the recurrent granulomatous epulis and assessed the complications.


METHODS
A total of 16 patients with recurrent granulomatous epulis underwent intralesional PYM injections, between July 2010 and June 2014. The effects and complications of the treatment were retrospectively reviewed.


RESULTS
The total number of injections performed was 48 (for all patients). The median number of injections per patient was three (range, two to four). All cases completely recovered with no recurrence and resorption of the alveolar bone after a follow-up of more than 12 months. The complications included slight bleeding, local swelling and pain following injection. All these symptoms resolved 7 to 10 days after the injection.


CONCLUSIONS
In summary, intralesional PYM injections may be a preferred option for recurring granulomatous epulis.
Department of Oral and Maxillofacial Surgery, School and Hospital of Stomatology, Wuhan University, 237, LuoYu Road, Wuhan, 430079, P. R. China, jhzhao988@whu.edu.cn.
Y
Y
Cai
R
R
Sun
K-F
KF
He
Y-F
YF
Zhao
J-H
JH
Zhao
D000293:Adolescent; D000328:Adult; D001761:Bleomycin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D002648:Child; D005260:Female; D005882:Gingival Diseases / Q000628:therapy*; D006099:Granuloma / Q000628:therapy*; D006801:Humans; D008297:Male; D012008:Recurrence; D012189:Retrospective Studies; D015911:Sclerotherapy; D055815:Young Adult
D001761:Bleomycin; C025703:bleomycetin